| Literature DB >> 28567283 |
Nita Chahal1, Janet Rush2, Cedric Manlhiot1, Katherine M Boydell3, Ahlexxi Jelen1, Brian W McCrindle1.
Abstract
BACKGROUND: Lifestyle management for dyslipidemic adolescents often occurs in the context of family-centered care, which necessitates adaptation of counseling strategies.Entities:
Keywords: Motivational interviewing; adolescents; cardiovascular risk; dyslipidemia; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; obesity; overweight; total cholesterol; triglycerides
Year: 2017 PMID: 28567283 PMCID: PMC5438108 DOI: 10.1177/2050312117707152
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Question template for participant interviews at the 6-month study endpoint.
| Interview Script Template | |
|---|---|
| 1. | Tell me how you felt when you were first told about your cholesterol. Who told you? Who did you tell about this? What did you talk about? |
| 2. | Your family doctor then referred you to The Hospital for Sick Children (Sick Kids). How did that make you feel, coming to a special clinic? |
| 3. | Describe what you remember about your first visit at Sick Kids. Can you tell me what you remember from the education session that day? |
| 4. | You then took part in this study where you had special counseling (with both of you alone). In what ways were these sessions (with the nurse practitioner) different from the first large, education session? |
| 5. | The special counseling sessions are known to help motivate kids to make positive changes/decisions and achieve to their goals. What about you? What do you think? |
| 6. | Think about a kid who’s in a similar situation as you (someone who has high cholesterol and is trying to achieve a healthy weight) … What are some of the things that you would tell this person? |
| 7. | Would you recommend this study’s methods (the “sessions” with your counselor) to others in situations like yours? What would you tell them? |
| 8. | You made changes, right? Did you make your own decisions? Who specifically was involved in helping you? How? What helped you stay on track? Did anything else help? |
| 9. | What other things come to mind when you think about being part of this research study? In the future, would you choose to be in a study? Why/why not? |
Figure 1.Study trial CONSORT-flow diagram.
Changes in physical measures.
| N | Adolescent/parent dyad (baseline) | N | Adolescent alone (baseline) | p | N | Adolescent/parent dyad (6 months) | N | Adolescent alone (6 months) | p | p | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demographic data | ||||||||||||
| Gender (male) | 16 | 10 (63%) | 16 | 10 (63%) | 1.00 | |||||||
| Age (mean ± SD) | 16 | 12.8 ± 2.2 | 16 | 13.7 ± 2.5 | 0.62 | 16 | 13.2 ± 2.2 | 16 | 14.2 ± 2.5 | |||
| Weight (kg) | 16 | 75.6 ± 20.6 | 16 | 81.9 ± 21.3 | 0.41 | 16 | 75.0 ± 21.9 | 16 | 79.0 ± 18.6 | 0.59 | 0.14 | 0.03 |
| Height (cm) | 16 | 160 ± 12 | 16 | 160 ± 10 | 0.87 | 16 | 163 ± 12 | 16 | 163 ± 10 | 0.97 | 0.28 | <0.001 |
| BMI (kg/m2) | 16 | 29.2 ± 4.7 | 16 | 31.5 ± 6.4 | 0.24 | 16 | 27.8 ± 4.9 | 16 | 29.6 ± 5.7 | 0.35 | 0.32 | <0.001 |
| Waist (cm) | 16 | 98.3 ± 11.9 | 16 | 102.8 ± 13.8 | 0.32 | 16 | 93.1 ± 12.8 | 16 | 95.1 ± 13.0 | 0.66 | 0.12 | <0.001 |
| Waist-to-height ratio | 16 | 0.62 ± 0.05 | 16 | 0.64 ± 0.08 | 0.28 | 16 | 0.57 ± 0.06 | 16 | 0.59 ± 0.08 | 0.58 | 0.19 | <0.001 |
| Blood pressure systolic (mmHg) | 16 | 124 ± 14 | 16 | 125 ± 20 | 0.76 | 16 | 121 ± 11 | 16 | 117 ± 11 | 0.35 | 0.37 | 0.08 |
| Blood pressure systolic z-score | 16 | 1.32 ± 1.28 | 16 | 1.44 ± 1.90 | 0.84 | 16 | 0.94 ± 0.96 | 16 | 0.53 ± 0.93 | 0.24 | 0.38 | 0.04 |
| Blood pressure diastolic (mmHg) | 16 | 65 ± 8 | 16 | 67 ± 5 | 0.49 | 16 | 64 ± 11 | 16 | 65 ± 12 | 0.88 | 0.79 | 0.4 |
| Blood pressure diastolic z-score | 16 | 0.10 ± 0.79 | 16 | 0.23 ± 0.50 | 0.61 | 16 | −0.05 ± 1.10 | 16 | −0.03 ± 1.15 | 0.95 | 0.79 | 0.28 |
| Body composition | ||||||||||||
| Percentage of fat mass | 16 | 39 ± 9 | 16 | 39 ± 8 | 0.98 | 16 | 39 ± 8 | 16 | 37 ± 9 | 0.97 | 0.98 | 0.03 |
| Percentage of fat-free mass | 16 | 61 ± 9 | 16 | 61 ± 8 | 0.98 | 16 | 61 ± 8 | 16 | 63 ± 9 | 0.97 | 0.98 | 0.03 |
| Body fat rating for male | 10 | 10 | 10 | 10 | ||||||||
| Risky body fat (>30.0%) | 8 (80%) | 8 (80%) | 6 (60%) | 6 (60%) | ||||||||
| Excess fat (20.1%–30.0%) | 1 (10%) | 2 (20%) | 3 (30%) | 4 (40%) | ||||||||
| Moderately lean (12.1%–20.0%) | 1 (10%) | 0 (0%) | 1 (10%) | 0 (0%) | ||||||||
| Body fat rating for female | 6 | 6 | 6 | 6 | ||||||||
| Risky body fat (>40%) | 4 (67%) | 3 (50%) | 2 (33%) | 2 (33%) | ||||||||
| Excess fat (30.1%–40.0%) | 2 (33%) | 2 (33%) | 4 (67%) | 3 (50%) | ||||||||
| Moderately lean (22.1%–30.0%) | 0 (0%) | 1 (17%) | 0 (0%) | 1 (17%) | ||||||||
| Vascular | ||||||||||||
| PWVcr (m/s) | 16 | 6.9 ± 1.2 | 16 | 6.6 ± 0.8 | 0.89 | 16 | 6.9 ± 0.8 | 16 | 6.8 ± 0.9 | 0.45 | 0.52 | 0.12 |
| PWVcf (m/s) | 16 | 5.5 ± 0.9 | 16 | 5.3 ± 0.7 | 0.72 | 16 | 5.4 ± 0.7 | 16 | 5.4 ± 0.6 | 0.86 | 0.52 | 0.22 |
SD: standard deviation; BMI: body mass index; PWVcr: carotid-radial pulse wave velocity; PWVcf: carotid-femoral pulse wave velocity.
p value of the interaction of group (adolescent/parent dyad vs adolescent alone) by time (baseline vs 6 months).
p value of the change from baseline to 6 months (all patients combined).
Changes in laboratory measures.
| N | Adolescent/parent dyad (baseline) | N | Adolescent alone (baseline) | p | N | Adolescent/parent dyad (6 months) | N | Adolescent alone (6 months) | p | p | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipid profile | ||||||||||||
| TC (mmol/L) | 16 | 5.4 ± 0.5 | 16 | 5.3 ± 0.6 | 0.59 | 16 | 4.7 ± 0.9 | 16 | 4.7 ± 0.8 | 0.96 | 0.58 | <0.001 |
| LDL-C (mmol/L) | 16 | 3.3 ± 0.4 | 14 | 3.2 ± 0.5 | 0.33 | 15 | 2.9 ± 0.7 | 14 | 2.8 ± 0.6 | 0.58 | 0.66 | <0.001 |
| HDL-C (mmol/L) | 16 | 1.1 ± 0.2 | 16 | 1.2 ± 0.3 | 0.19 | 16 | 1.1 ± 0.2 | 16 | 1.1 ± 0.3 | 0.43 | 0.44 | 0.25 |
| TG (mmol/L) | 16 | 1.9 ± 0.8 | 16 | 2.5 ± 1.2 | 0.12 | 16 | 1.7 ± 1.0 | 16 | 1.8 ± 1.2 | 0.81 | 0.16 | 0.01 |
| Non-HDL-C (mmol/L) | 16 | 4.3 ± 0.6 | 16 | 4.1 ± 0.5 | 0.23 | 16 | 3.6 ± 0.9 | 16 | 3.6 ± 0.8 | 0.81 | 0.43 | <0.001 |
| TG/HDL-C ratio | 16 | 2.0 ± 1.2 | 16 | 2.3 ± 1.5 | 0.52 | 16 | 1.8 ± 1.5 | 16 | 1.8 ± 1.5 | 0.98 | 0.45 | 0.13 |
| TC/HDL-C ratio | 16 | 5.3 ± 1.3 | 16 | 4.6 ± 0.8 | 0.09 | 16 | 4.6 ± 1.3 | 16 | 4.4 ± 1.4 | 0.65 | 0.16 | 0.03 |
| HDL-C/TC ratio | 16 | 0.20 ± 0.05 | 16 | 0.23 ± 0.05 | 0.13 | 16 | 0.23 ± 0.06 | 16 | 0.25 ± 0.04 | 0.49 | 0.52 | 0.003 |
| Apo B | 16 | 0.99 ± 0.14 | 16 | 0.92 ± 0.20 | 0.26 | 16 | 0.93 ± 0.20 | 16 | 0.91 ± 0.21 | 0.77 | 0.37 | 0.19 |
| Glycemic profile | ||||||||||||
| Fasting glucose (mmol/L) | 16 | 5.0 ± 0.4 | 16 | 5.1 ± 0.4 | 0.49 | 16 | 5.1 ± 0.3 | 16 | 5.1 ± 0.4 | 1.00 | 0.43 | 0.89 |
| Fasting insulin (pmol/L) | 16 | 130 ± 67 | 16 | 113 ± 76 | 0.50 | 16 | 104 ± 66 | 16 | 92 ± 42 | 0.54 | 0.77 | 0.01 |
| HOMA-IR | 16 | 4.2 ± 2.1 | 16 | 3.8 ± 2.6 | 0.61 | 16 | 3.4 ± 2.2 | 16 | 3.1 ± 1.6 | 0.64 | 0.87 | 0.02 |
| Other serology | ||||||||||||
| AST (U/L) | 16 | 28.3 ± 8.9 | 16 | 27.8 ± 8.5 | 0.86 | 16 | 25.2 ± 5.1 | 16 | 25.8 ± 7.5 | 0.81 | 0.71 | 0.11 |
| AST < 40 U/L | 16 | 14 (88%) | 16 | 14 (88%) | 1.00 | 16 | 16 (100%) | 16 | 14 (88%) | 0.49 | 0.32 | |
| ALT (U/L) | 16 | 40.1 ± 18.8 | 16 | 37.6 ± 15.7 | 0.69 | 16 | 32.2 ± 9.2 | 16 | 31.7 ± 12.3 | 0.90 | 0.74 | 0.03 |
| ALT < 40 U/L | 16 | 10 (63%) | 16 | 10 (63%) | 1.00 | 16 | 13 (81%) | 16 | 12 (75%) | 1.00 | 0.71 | 0.13 |
| hs-CRP (mg/L) | 16 | 1.3 (0.8–2.7) | 16 | 1.4 (1.0–5.1) | 0.21 | 16 | 1.0 (0.6–2.4) | 16 | 1.8 (0.8–3.3) | 0.89 | 0.16 | 0.95 |
| hs-CRP < 0.7 mg/L | 16 | 3 (19%) | 16 | 3 (19%) | 1.00 | 16 | 5 (31%) | 16 | 2 (13%) | 0.39 | 0.23 | 0.71 |
TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; TG/HDL-C ratio: calculated triglyceride-to-high-density lipoprotein cholesterol ratio; TC/HDL-C ratio: calculated total cholesterol-to-high-density lipoprotein cholesterol ratio; HDL-C/TC ratio: calculated high-density lipoprotein cholesterol-to-total cholesterol ratio; HOMA-IR: homeostatic model assessment for insulin resistance; AST: aspartate aminotransferase; ALT: alanine aminotransferase; Apo B: apolipoprotein B; hs-CRP: high-sensitivity C-reactive protein.
p value of the interaction of groups (adolescent/parent dyad vs adolescent alone) by time (baseline vs 6 months).
p value of the change baseline to 6 months (all patients combined).
Changes in lifestyle measures.
| N | Adolescent parent dyad (baseline) | N | Adolescent alone (baseline) | p | N | Adolescent/parent dyad (6 months) | N | Adolescent alone (6 months) | p | p | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Vegetables (servings/day) | 16 | 1 (0–1) | 16 | 1 (0–2) | 0.93 | 16 | 2 (1–3) | 14 | 2 (1–4) | 0.80 | 0.95 | 0.003 |
| None | 4 (25%) | 6 (38%) | 0.89 | 2 (13%) | 2 (14%) | 1.00 | 0.92 | 0.01 | ||||
| 1–2 | 9 (56%) | 7 (44%) | 6 (38%) | 6 (43%) | ||||||||
| 3–7 | 3 (19%) | 3 (19%) | 8 (50%) | 6 (43%) | ||||||||
| Fruits and fruit juices (servings/day) | 16 | 1 (1–2) | 16 | 1 (1–2) | 0.80 | 16 | 2 (1–2) | 14 | 2 (1–2) | 0.47 | 0.60 | 0.15 |
| None | 2 (13%) | 3 (19%) | 1.00 | 3 (19%) | 1 (7%) | 0.75 | 0.43 | 0.78 | ||||
| 1–2 | 11 (69%) | 10 (63%) | 10 (63%) | 10 (71%) | ||||||||
| 3–4 | 3 (19%) | 3 (19%) | 3 (19%) | 3 (21%) | ||||||||
| Breads/cereals/rice/pasta (servings/day) | 16 | 3 (2–4) | 16 | 3 (2–5) | 0.77 | 16 | 3 (2–4) | 14 | 3 (2–3) | 0.49 | 0.36 | 0.24 |
| 0–1 | 2 (13%) | 1 (6%) | 1.00 | 3 (19%) | 3 (21%) | 1.00 | 0.49 | 0.08 | ||||
| 2–5 | 12 (75%) | 12 (75%) | 12 (75%) | 10 (71%) | ||||||||
| 6–8 | 2 (13%) | 3 (19%) | 1 (6%) | 1 (7%) | ||||||||
| Meat/fish/poultry/beans/egg (servings/day) | 16 | 1 (1–2) | 16 | 1 (1–1) | 0.07 | 16 | 1 (1–2) | 14 | 1 (0–1) | 0.24 | 0.65 | 0.55 |
| None | 0 (0%) | 2 (13%) | 0.27 | 2 (13%) | 6 (43%) | 0.07 | 0.19 | 0.43 | ||||
| 1 | 10 (63%) | 11 (69%) | 6 (38%) | 6 (43%) | ||||||||
| 2–4 | 6 (38%) | 3 (19%) | 8 (50%) | 2 (14%) | ||||||||
| Milk/yogurt/cheese (servings/day) | 16 | 1 (1–2) | 16 | 1 (1–1) | 0.25 | 16 | 2 (1–2) | 14 | 1 (1–2) | 0.60 | 0.68 | 0.40 |
| None | 1 (6%) | 4 (25%) | 0.31 | 3 (19%) | 1 (7%) | 0.41 | 0.37 | 0.24 | ||||
| 1 | 9 (56%) | 9 (56%) | 5 (31%) | 8 (57%) | ||||||||
| 2–3 | 6 (38%) | 3 (19%) | 8 (50%) | 5 (36%) | ||||||||
| Fats and oils/sweets/sodas (servings/day) | 16 | 2 (1–3) | 16 | 2 (1–3) | 0.47 | 16 | 2 (1–2) | 14 | 1 (0–2) | 0.03 | 0.05 | 0.001 |
| None | 1 (6%) | 0 (0%) | 1.00 | 1 (6%) | 4 (29%) | 0.14 | 0.02 | 0.001 | ||||
| 1–2 | 9 (56%) | 9 (56%) | 13 (81%) | 10 (71%) | ||||||||
| 3–6 | 6 (38%) | 7 (44%) | 2 (13%) | 0 (0%) | ||||||||
|
| ||||||||||||
| Total score (# /10) | 16 | 3.0 (2.3–4.0) | 16 | 4.0 (2.5–5.0) | 0.41 | 16 | 7.5 (6.0–8.5) | 16 | 7.5 (6.0–8.3) | 0.92 | 0.51 | <0.001 |
| Poor (0–2.5) | 9 (56%) | 6 (38%) | 0.48 | 1 (6%) | 0 (0%) | 0.72 | 0.39 | <0.001 | ||||
| Fair to good (3.0–5.0) | 7 (44%) | 10 (63%) | 5 (31%) | 7 (44%) | ||||||||
| Very good to excellent (⩾5.5) | 0 (0%) | 0 (0%) | 10 (63%) | 9 (56%) | ||||||||
| Physical activity | ||||||||||||
| Physical activity time (h/week) | 16 | 0 (0–1) | 16 | 0 (0–1) | 0.74 | 16 | 12 (8–15) | 16 | 10 (7–14) | 0.60 | 0.57 | <0.001 |
|
| ||||||||||||
| MVPA (min/day) | 11 | 11 (7–14) | 13 | 11 (8–15) | 0.74 | 13 | 10 (5–20) | 12 | 9 (7–11) | 0.73 | 0.77 | 0.56 |
| Steps (×1000/day) | 11 | 2.05 ± 0.63 | 13 | 2.16 ± 0.77 | 0.69 | 13 | 1.78 ± 1.17 | 12 | 2.15 ± 1.16 | 0.44 | 0.45 | 0.26 |
|
| ||||||||||||
| Cumulative screen time (h/week) | 16 | 26 (22–33) | 16 | 34 (23–46) | 0.14 | 16 | 17 (11–23) | 16 | 14 (10–15) | 0.13 | 0.02 | <0.001 |
|
| ||||||||||||
| Sleep time (h/day) | 16 | 9 (8–9) | 16 | 9 (8–9) | 0.31 | 16 | 9 (8–10) | 16 | 9 (8–10) | 0.45 | 0.32 | 0.42 |
MVPA: moderate to vigorous physical activity.
p value of the interaction of group (adolescent/parent dyad vs adolescent alone) by time (baseline vs 6 months).
p value of the change from baseline to 6 months (all patients combined).
Changes in lifestyle measures (The Heart Niagara Questionnaire).
| N | Adolescent /parent dyad (baseline) | N | Adolescent Alone (baseline) | p | N | Adolescent /parent dyad (6 months) | N | Adolescent Alone (6 months) | p | p | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Niagara Questionnaire | ||||||||||||
|
| 16 | 16 | 1.00 | 16 | 15 | 0.84 | 0.70 | 0.71 | ||||
| Poor | 2 (13%) | 3 (19%) | 2 (13%) | 2 (13%) | ||||||||
| Fair to good | 12 (75%) | 11 (69%) | 11 (69%) | 12 (80%) | ||||||||
| Very good to excellent | 2 (13%) | 2 (13%) | 3 (19%) | 1 (7%) | ||||||||
|
| 14 | 16 | 0.59 | 16 | 15 | 1.00 | 0.08 | 0.19 | ||||
| Poor | 1 (7%) | 3 (19%) | 1 (6%) | 1 (7%) | ||||||||
| Fair to good | 8 (57%) | 10 (63%) | 10 (63%) | 9 (60%) | ||||||||
| Very good to excellent | 5 (36%) | 3 (19%) | 5 (31%) | 5 (33%) | ||||||||
|
| 16 | 16 | 0.82 | 16 | 15 | 1.00 | 0.66 | 0.34 | ||||
| Almost always or always | 1 (6%) | 0 (0%) | 0 (0%) | 0 (0%) | ||||||||
| Sometimes | 5 (31%) | 6 (38%) | 4 (25%) | 5 (33%) | ||||||||
| Almost never or never | 5 (31%) | 8 (50%) | 6 (38%) | 9 (60%) | ||||||||
| Not applicable | 5 (31%) | 2 (13%) | 6 (38%) | 1 (7%) | ||||||||
|
| 16 | 16 | 0.14 | 16 | 15 | 0.39 | 0.64 | 0.15 | ||||
| 0–3 times | 3 (19%) | 8 (50%) | 2 (13%) | 4 (27%) | ||||||||
| 4–7 times | 13 (81%) | 8 (50%) | 14 (88%) | 11 (73%) | ||||||||
|
| 16 | 16 | 1.00 | 16 | 15 | 0.65 | 0.31 | 0.84 | ||||
| Definitely/mostly true | 3 (19%) | 4 (25%) | 4 (25%) | 2 (13%) | ||||||||
| Definitely/mostly false | 13 (81%) | 12 (75%) | 12 (75%) | 13 (87%) | ||||||||
|
| 15 | 16 | 0.69 | 16 | 15 | 1.00 | 0.84 | 0.50 | ||||
| Definitely/mostly true | 4 (27%) | 3 (19%) | 3 (19%) | 2 (13%) | ||||||||
| Definitely/mostly false | 11 (73%) | 13 (81%) | 13 (81%) | 13 (87%) | ||||||||
|
| 14 | 4 ± 2 | 14 | 4 ± 2 | 0.42 | 16 | 6 ± 2 | 14 | 5 ± 2 | 0.66 | 0.85 | <0.001 |
| 1–2 | 2 (14%) | 4 (29%) | 0.76 | 1 (6%) | 1 (7%) | 0.66 | 0.98 | 0.003 | ||||
| 3–5 | 9 (64%) | 8 (57%) | 5 (31%) | 5 (36%) | ||||||||
| 6–8 | 3 (21%) | 2 (14%) | 10 (62%) | 7 (50%) | ||||||||
|
| 15 | 15 | 1.00 | 16 | 15 | 0.47 | 0.38 | 0.38 | ||||
| <30 | 7 (47%) | 7 (47%) | 5 (31%) | 7 (47%) | ||||||||
| >30 | 8 (53%) | 8 (53%) | 11 (69%) | 8 (53%) | ||||||||
|
| 15 | 15 | 0.32 | 16 | 15 | 0.52 | 0.36 | 0.02 | ||||
| ⩽1 | 7 (47%) | 5 (33%) | 9 (56%) | 10 (67%) | ||||||||
| 2 | 2 (13%) | 6 (40%) | 3 (19%) | 4 (27%) | ||||||||
| ⩾3 | 6 (40%) | 4 (27%) | 4 (25%) | 1 (7%) | ||||||||
|
| 15 | 16 | 0.06 | 16 | 14 | 0.37 | 0.87 | 0.004 | ||||
| ⩽1 | 10 (67%) | 4 (25%) | 14 (88%) | 9 (64%) | ||||||||
| 2 | 2 (13%) | 7 (44%) | 1 (6%) | 2 (14%) | ||||||||
| ⩾3 | 3 (20%) | 5 (31%) | 1 (6%) | 3 (21%) | ||||||||
|
| 15 | 16 | 0.48 | 16 | 14 | 1.00 | 0.98 | 0.62 | ||||
| 0 | 4 (27%) | 6 (38%) | 5 (31%) | 4 (29%) | ||||||||
| ⩽2 | 8 (53%) | 5 (31%) | 8 (50%) | 8 (57%) | ||||||||
| ⩾3 | 3 (20%) | 5 (31%) | 3 (19%) | 2 (14%) | ||||||||
|
| 15 | 16 | 1.00 | 16 | 14 | 0.88 | 0.82 | 0.07 | ||||
| 0–10 | 7 (47%) | 6 (38%) | 10 (63%) | 7 (50%) | ||||||||
| 11–30 | 3 (20%) | 4 (25%) | 2 (13%) | 3 (21%) | ||||||||
| ⩾31 | 5 (33%) | 6 (38%) | 4 (25%) | 4 (29%) | ||||||||
|
| 15 | 15 (100%) | 15 | 15 (100%) | 1.00 | 16 | 16 (100%) | 14 | 14 (100%) | 1.00 | ||
p value of the interaction of groups (adolescent/parent dyad vs adolescent alone) by time (baseline vs 6 months).
p value of the change from baseline to 6 months (all patients combined).
Changes in psychosocial measures.
| N | Adolescent /parent dyad (baseline) | N | Adolescent alone (baseline) | p | N | Adolescent /parent dyad (6 months) | N | Adolescent alone (6 months) | p | p | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pediatric Quality of Life Questionnaire | ||||||||||||
| Physical functioning | 14 | 66 ± 26 | 14 | 69 ± 23 | 0.69 | 16 | 76 ± 24 | 15 | 81 ± 22 | 0.61 | 0.93 | 0.03 |
| Emotional functioning | 14 | 74 ± 26 | 14 | 67 ± 25 | 0.44 | 16 | 78 ± 27 | 15 | 72 ± 22 | 0.56 | 0.79 | 0.03 |
| Social functioning | 14 | 73 ± 22 | 14 | 71 ± 19 | 0.75 | 16 | 83 ± 24 | 15 | 83 ± 20 | 0.97 | 0.94 | 0.01 |
| School functioning | 14 | 69 ± 24 | 14 | 62 ± 22 | 0.48 | 16 | 68 ± 25 | 15 | 74 ± 18 | 0.46 | 0.30 | 0.29 |
| Self-Efficacy Questionnaire for Children | ||||||||||||
| Total self-efficacy | 16 | 28 ± 7 | 16 | 29 ± 6 | 0.59 | 16 | 31 ± 6 | 15 | 31 ± 6 | 0.82 | 0.61 | 0.004 |
| Social self-efficacy | 16 | 30 ± 6 | 16 | 29 ± 6 | 0.78 | 16 | 32 ± 6 | 15 | 30 ± 5 | 0.44 | 0.64 | 0.10 |
| Emotional self-efficacy | 16 | 26 ± 6 | 16 | 26 ± 6 | 0.85 | 16 | 29 ± 5 | 15 | 27 ± 7 | 0.45 | 0.32 | 0.02 |
| Rosenberg Self-Esteem Scale | ||||||||||||
| Sum of all scores | 16 | 20 (18–23) | 16 | 21 (16–24) | 0.93 | 16 | 25 (20–26) | 15 | 22 (18–27) | 0.49 | 0.25 | 0.03 |
A higher reported score means a higher level of functioning as defined in Pediatric Quality of Life Questionnaire, Self-Efficacy Questionnaire for Children, and Rosenberg Self-Esteem Scale.
p value of the interaction of groups (adolescent/parent dyad vs adolescent alone) by time (baseline vs 6 months).
p value of the change from baseline to 6 months (all patients combined).
Figure 2.Changes in lipid profile between baseline and follow-up for both groups combined (adolescent/parent dyad and adolescent alone groups).
TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; non-HDL-C: non–high-density lipoprotein cholesterol.
Characteristics of adolescents “readiness” to change.
| Adolescent/parent dyad | Adolescent alone | Combined | ||||
|---|---|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | Baseline | 6 months | |
| Physical activity stages | ||||||
| 1. Pre-contemplation | 0 (0%) | 0 (0%) | 1 (6%) | 0 (0%) | 1 (3%) | 0 (0%) |
| 2. Contemplation | 6 (38%) | 1 (6%) | 9 (56%) | 1 (7%) | 15 (47%) | 2 (6%) |
| 3. Preparation | 1 (6%) | 0 (0%) | 1 (6%) | 3 (20%) | 2 (6%) | 3 (10%) |
| 4. Decision/action | 3 (19%) | 5 (31%) | 0 (0%) | 0 (0%) | 3 (9%) | 5 (16%) |
| 5. Maintenance | 6 (38%) | 10 (63%) | 5 (31%) | 11 (73%) | 11 (34%) | 21 (68%) |
| Healthy eating stages | ||||||
| 1. Pre-contemplation | 0 (0%) | 1 (6%) | 3 (19%) | 2 (14%) | 3 (9%) | 3 (10%) |
| 2. Contemplation | 9 (56%) | 2 (13%) | 8 (50%) | 0 (0%) | 17 (53%) | 2 (7%) |
| 3. Preparation | 5 (31%) | 8 (50%) | 3 (19%) | 6 (43%) | 8 (25%) | 14 (47%) |
| 4. Decision/action | 0 (0%) | 0 (0%) | 0 (0%) | 1 (7%) | 0 (0%) | 1 (3%) |
| 5. Maintenance | 2 (13%) | 5 (31%) | 2 (13%) | 5 (36%) | 4 (13%) | 10 (33%) |
| Screen time stages | ||||||
| 1. Pre-contemplation | 2 (13%) | 0 (0%) | 4 (27%) | 3 (20%) | 6 (19%) | 3 (10%) |
| 2. Contemplation | 10 (63%) | 2 (13%) | 4 (27%) | 3 (20%) | 14 (45%) | 5 (16%) |
| 3. Preparation | 2 (13%) | 4 (25%) | 6 (40%) | 1 (7%) | 8 (26%) | 5 (16%) |
| 4. Decision/action | 1 (6%) | 4 (25%) | 1 (7%) | 3 (20%) | 2 (6%) | 7 (23%) |
| 5. Maintenance | 1 (6%) | 6 (38%) | 0 (0%) | 5 (33%) | 1 (3%) | 11 (35%) |